Edward Abrahams, Ph.D., is the President of PMC. Representing innovators, scientists, patients, providers and payors, PMC promotes the understanding and adoption of personalized medicine concepts, services and products for the benefit of patients and the health system. It has grown from its original 18 founding members in 2004 to more than 225 today.
Previously, Dr. Abrahams was the Executive Director of the Pennsylvania Biotechnology Association, where he spearheaded the successful effort that led to the Commonwealth of Pennsylvania’s investment of $200 million to commercialize biotechnology in the state. Earlier he had been Assistant Vice President for Federal Relations at the University of Pennsylvania and held a senior administrative position at Brown University.
Dr. Abrahams worked for seven years for the U.S. Congress, including as a legislative assistant to Senator Lloyd Bentsen, an economist for the Joint Economic Committee under the chairmanship of Representative Lee Hamilton, and as a AAAS Congressional Fellow for Representative Edward J. Markey.
The author of numerous essays, Dr. Abrahams serves on the editorial board of Personalized Medicine and has also taught history and public policy at Brown University and the University of Pennsylvania.
Senior Vice President, Science Policy
Vice President, Science Policy
Daryl Pritchard, Ph.D., is the Vice President of Science Policy at PMC, where he leads PMC efforts to develop and promote optimal science-related policies and to increase awareness and understanding of personalized medicine amongst health care providers, patients, policy decision-makers and other stakeholders. This includes working to identify and address barriers to the adoption of personalized medicine into the health care system, including the development and promotion of appropriate clinical, health care infrastructure, regulatory and payment policies.
Before coming to PMC, Dr. Pritchard served as the Director of Policy Research at the National Pharmaceutical Council (NPC), where he directed NPC’s policy research efforts in the areas of personalized medicine, the heterogeneity of treatment effects and the value of specialty biopharmaceuticals, and helped to advance NPC outreach, alliance development and government relations. Prior to joining NPC, Dr. Pritchard served as the Director of Research Programs Advocacy and Personalized Medicine at the Biotechnology Industry Organization (BIO), where he led the organization’s policy and research efforts regarding diagnostics and personalized therapies as well as coordination of BIO’s activities involving federal biomedical research programs. He also spent three years as the Director of Government Affairs for the American Association for Dental Research (AADR), and as the primary research policy coordinator for the American Dental Education Association (ADEA).
Dr. Pritchard received his Ph.D. and master’s degree in genetics from George Washington University, and completed a post-doctoral research fellowship at the Children’s National Medical Center. He was awarded the first American Society of Human Genetics (ASHG)/National Human Genome Research Institute (NHGRI) Fellowship in Genetics and Public Policy, where he worked as a health legislative assistant in the House of Representatives.
Vice President, Public Policy
Cynthia A. Bens Vice President, Public Policy
at the Personalized Medicine Coalition (PMC) leads the Coalition’s policy
development and government relations efforts and serves as the primary liaison
with the U.S. Congress and federal regulators. In collaboration with the PMC’s
Senior Vice President, Science Policy, Ms. Bens is responsible for implementing
research, regulatory and reimbursement policy strategies that promote the
understanding and adoption of personalized medicine concepts, services and products
to benefit patients and the health system.
Before joining the PMC, she was the Vice President of Public
Policy at the Alliance for Aging Research. Ms. Bens guided the Alliance’s
federal policy work, represented the organization in multiple national
coalitions, and directed all aspects of coalitions led by the Alliance. She spent
more than a decade at the Alliance advancing policies to expedite the
development of interventions for neurological diseases and physical frailty; to
remove access barriers for cardiovascular disease treatments; and to enhance
the quality of care for older adults living with multiple chronic conditions.
Prior to joining the Alliance, Ms. Bens was a senior manager of
government affairs with the Loeffler Group. As part of its federal government
affairs practice, she represented client interests before the U.S. Congress and
the administration. Her core areas of focus included appropriations, budget,
health care, education, telecommunications and international trade. Through various
other positions on Capitol Hill and in the private sector, she has acquired
extensive experience researching and analyzing federal legislation and
Ms. Bens holds a Bachelors of Arts degree from New York University
with concentrations in political science and women’s studies.
Director, Operations & Secretary to the Board
Associate Director, Membership & Development